EDITORIAL
Published on 31 Oct 2022
Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments
doi 10.3389/fimmu.2022.1065937
- 840 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Improvement of Melanoma Immune Checkpoint Blockade Therapy with Potential Combinatorial Regiments
Improvement of Melanoma Immune Checkpoint Blockade Therapy with Potential Combinatorial Regiments
22k
Total downloads
69k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 01 Jul 2022
CCND1 Amplification Profiling Identifies a Subtype of Melanoma Associated With Poor Survival and an Immunosuppressive Tumor Microenvironment
doi 10.3389/fimmu.2022.725679
- 5,370 views
- 13 citations
ORIGINAL RESEARCH
Published on 20 Dec 2021
Improvement of PD-1 Blockade Efficacy and Elimination of Immune-Related Gastrointestinal Adverse Effect by mTOR Inhibitor
doi 10.3389/fimmu.2021.793831
- 4,083 views
- 20 citations
CASE REPORT
Published on 05 Oct 2021
Case Report: Sustained Remission Due to PD-1-Inhibition in a Metastatic Melanoma Patient With Depleted B Cells
doi 10.3389/fimmu.2021.733961
- 1,951 views
- 5 citations
ORIGINAL RESEARCH
Published on 06 Jul 2021
Enhanced Antitumor Response to Immune Checkpoint Blockade Exerted by Cisplatin-Induced Mutagenesis in a Murine Melanoma Model
doi 10.3389/fonc.2021.701968
- 3,048 views
- 6 citations
REVIEW
Published on 05 Jul 2021
Telomerase as a Target for Therapeutic Cancer Vaccines and Considerations for Optimizing Their Clinical Potential
doi 10.3389/fimmu.2021.682492
- 10,168 views
- 29 citations
ORIGINAL RESEARCH
Published on 17 Jun 2021
9-Gene Signature Correlated With CD8+ T Cell Infiltration Activated by IFN-γ: A Biomarker of Immune Checkpoint Therapy Response in Melanoma
doi 10.3389/fimmu.2021.622563
- 12,168 views
- 34 citations
REVIEW
Published on 04 Jun 2021
Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions
doi 10.3389/fimmu.2021.680407
- 18,495 views
- 109 citations
ORIGINAL RESEARCH
Published on 20 May 2021
Risk Models for Advanced Melanoma Patients Under Anti-PD-1 Monotherapy—Ad hoc Analyses of Pooled Data From Two Clinical Trials
doi 10.3389/fonc.2021.639085
- 1,665 views
- 8 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore